Harmony Biosciences

Plymouth Meeting, United States Founded: 2017 • Age: 9 yrs
Developer of therapeutics for rare neurological diseases
Request Access

About Harmony Biosciences

Harmony Biosciences is a company based in Plymouth Meeting (United States) founded in 2017.. Harmony Biosciences has raised $345 million across 6 funding rounds from investors including Fidelity Investments, Orbimed and HBM Healthcare Investments. The company has 268 employees as of December 31, 2024. Harmony Biosciences has completed 1 acquisition, including Zynerba Pharma. Harmony Biosciences offers products and services including ZYN002. Harmony Biosciences operates in a competitive market with competitors including QurAlis, Passage Bio, Evox Therapeutics, MindMed and Relmada, among others.

  • Headquarter Plymouth Meeting, United States
  • Employees 268 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Harmony Biosciences Holdings, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $714.73 M
    22.8
    as on Dec 31, 2024
  • Net Profit
    $145.49 M
    12.91
    as on Dec 31, 2024
  • EBITDA
    $214.94 M
    -0.67
    as on Dec 31, 2024
  • Total Equity Funding
    $345 M (USD)

    in 6 rounds

  • Latest Funding Round
    $200 M (USD), Debt – Conventional

    Jan 27, 2020

  • Investors
  • Employee Count
    268

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Harmony Biosciences

Harmony Biosciences is a publicly listed company on the NASDAQ with ticker symbol HRMY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: HRMY . Sector: Health technology · USA

Products & Services of Harmony Biosciences

Harmony Biosciences offers a comprehensive portfolio of products and services, including ZYN002. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Treatment for Fragile X Syndrome in neurological patients

People of Harmony Biosciences
Headcount 50-200
Employee Profiles 76
Board Members and Advisors 8
Employee Profiles
People
Paul Ferguson
Director Of Accounting Operations
People
Nichole McBride
Manager, Corporate Events
People
Alexis DeAngelo
Executive Administrative Assistant to Chief Executive Officer
People
Mary Bordic
Director, Medical Information

Unlock access to complete

Board Members and Advisors
people
Gary Sender
Director

Unlock access to complete

Funding Insights of Harmony Biosciences

Harmony Biosciences has successfully raised a total of $345M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $200 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Debt – Conventional — $200.0M
  • First Round

    (22 Sep 2017)

  • Investors Count 10
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2020 Amount Debt – Conventional - Harmony Biosciences Valuation

investors

Aug, 2019 Amount Series E - Harmony Biosciences Valuation

investors

Mar, 2019 Amount Debt – Conventional - Harmony Biosciences Valuation

investors

CRG
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Harmony Biosciences

Harmony Biosciences has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, Orbimed and HBM Healthcare Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
CRG is recognized as a premier healthcare investment partner.
Founded Year Domain Location
PE firm investing in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Harmony Biosciences

Harmony Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Zynerba Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Transdermal cannabinoid therapies are developed for neurological disorders.
2007
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Harmony Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Harmony Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Harmony Biosciences

Harmony Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QurAlis, Passage Bio, Evox Therapeutics, MindMed and Relmada, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drugs and CSF devices are developed for ALS treatment.
domain founded_year HQ Location
Gene therapies for CNS rare diseases are developed.
domain founded_year HQ Location
Exosome-based gene therapies for neurological diseases are developed.
domain founded_year HQ Location
Psychedelic-based therapies for brain health disorders are developed.
domain founded_year HQ Location
Novel drug products for chronic pain treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Harmony Biosciences

Frequently Asked Questions about Harmony Biosciences

When was Harmony Biosciences founded?

Harmony Biosciences was founded in 2017.

Where is Harmony Biosciences located?

Harmony Biosciences is headquartered in Plymouth Meeting, United States. It is registered at Plymouth Meeting, Pennsylvania, United States.

Is Harmony Biosciences a funded company?

Harmony Biosciences is a funded company, having raised a total of $345M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $200M, raised on Sep 22, 2017.

How many employees does Harmony Biosciences have?

As of Dec 31, 2024, the latest employee count at Harmony Biosciences is 268.

What is the annual revenue of Harmony Biosciences?

Annual revenue of Harmony Biosciences is $714.73M as on Dec 31, 2024.

What does Harmony Biosciences do?

Developer of therapeutics for rare neurological diseases. The company is engaged in the research, development, and commercialization of novel treatments for rare diseases mainly CNS disorders including Wakix for Narcolepsy.

Who are the top competitors of Harmony Biosciences?

Harmony Biosciences's top competitors include QurAlis, MindMed and Passage Bio.

What products or services does Harmony Biosciences offer?

Harmony Biosciences offers ZYN002.

Is Harmony Biosciences publicly traded?

Yes, Harmony Biosciences is publicly traded on NASDAQ under the ticker symbol HRMY.

How many acquisitions has Harmony Biosciences made?

Harmony Biosciences has made 1 acquisition, including Zynerba Pharma.

Who are Harmony Biosciences's investors?

Harmony Biosciences has 10 investors. Key investors include Fidelity Investments, Orbimed, HBM Healthcare Investments, CRG, and Aisling Capital.

What is Harmony Biosciences's ticker symbol?

The ticker symbol of Harmony Biosciences is HRMY on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available